Patents by Inventor Colleen S. Stein

Colleen S. Stein has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230374509
    Abstract: The present invention relates to an expression-based RNA therapeutic that uses virus-based delivery of anti-miR181 (TuD-181). The present invention provides a method for treatment of Parkinson's disease (PD) by administering an expression-based RNA therapeutic that uses virus-based delivery of anti-miR181 (TuD-181). The present invention provides a method for treatment of retinal degeneration by administering an expression-based RNA therapeutic that uses virus-based delivery of anti-miR181 (TuD-181).
    Type: Application
    Filed: March 10, 2023
    Publication date: November 23, 2023
    Inventors: Ryan L. Boudreau, Colleen S. Stein, Budd Tucker
  • Publication number: 20160038521
    Abstract: Certain embodiments of the present invention provide a method for treating or preventing juvenile neuronal ceroid lipofuscinosis (JNCL) in an animal comprising administering CBX, GRA, or GZA to the animal.
    Type: Application
    Filed: March 17, 2014
    Publication date: February 11, 2016
    Applicant: UNIVERSITY OF IOWA RESEARCH FOUNDATION
    Inventors: Beverly L. Davidson, Colleen S. Stein, Mark Schultz, Luis Tecedor, Tammy L. Kielian
  • Patent number: 7034010
    Abstract: Gene delivery vectors, such as, for example, recombinant FIV vectors, and methods of using such vectors are provided for use in treating or preventing retinal diseases of the eye and diseases of the brain associated with lysosomal storage disorders.
    Type: Grant
    Filed: January 31, 2003
    Date of Patent: April 25, 2006
    Assignees: Chiron Corporation, University of Iowa Research Foundation
    Inventors: Beverly Davidson, Douglas J. Jolly, Sybille L. Sauter, Colleen S. Stein, Thomas W. Dubensky, Jr., Jason A. Heth
  • Patent number: 6730297
    Abstract: Gene delivery vectors, for example, recombinant FIV vectors, and methods of using such vectors are provided for use in treating or preventing retinal diseases of the eye and diseases of the brain associated with lysosomal storage disorders.
    Type: Grant
    Filed: May 26, 2000
    Date of Patent: May 4, 2004
    Assignees: Chiron Corporation, University of Iowa Research Foundation
    Inventors: Beverly Davidson, Douglas J. Jolly, Sybille L. Sauter, Colleen S. Stein, Thomas W. Dubensky, Jr., Jason A. Heth
  • Publication number: 20030223963
    Abstract: Gene delivery vectors, such as, for example, recombinant FIV vectors, and methods of using such vectors are provided for use in treating or preventing retinal diseases of the eye and diseases of the brain associated with lysosomal storage disorders.
    Type: Application
    Filed: January 31, 2003
    Publication date: December 4, 2003
    Inventors: Beverly Davidson, Douglas J. Jolly, Sybille L. Sauter, Colleen S. Stein, Thomas W. Dubensky, Jason A. Heth